Drug Type Fusion protein |
Synonyms |
Target |
Mechanism CD38 modulators(Lymphocyte differentiation antigen CD38 modulators), SIRPα modulators(Signal-regulatory protein alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 07 Jan 2022 |